Thrombosis is the interruption of blood flow by a clot in the blood vessels. Deep Vein Thrombosis is when a clot forms in a deep vein, commonly in the lower limbs. A deep vein is one that is set deep in the body and carries a vast amount of blood. Risk factors for Deep Vein Thrombosis include pregnancy, recent fracture or broken bone, prolonged immobility, obesity, and treatment for cancer. Symptoms of Deep Vein Thrombosis include varicose veins, swelling in the extremities, discolored skin, and isolated pain. Deep Vein Thrombosis can be treated with blood thinning medications, enzymes that brake down the clot, and catheters to expand the affected vein.
Deep Vein Thrombosis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Deep Vein Thrombosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 1072 products for the study of Deep Vein Thrombosis that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Deep Vein Thrombosis is also known as deep vein thrombosis.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.